Výsledky vyhledávání - Oliver Groß

Upřesnit hledání
  1. 1
    Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling

    Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling Autor Oliver Groß

    Vydáno 2002
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

    Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies Autor Oliver Groß, Laura Perin, Constantinos Deltas

    Vydáno 2014
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    SGLT2 inhibitors: approved for adults and cats but not for children with CKD

    SGLT2 inhibitors: approved for adults and cats but not for children with CKD Autor Oliver Groß, Dieter Haffner, Franz Schaefer, Lutz T. Weber

    Vydáno 2024
    Získat plný text Získat plný text
    Editorial
    Přidat do oblíbených
    Uloženo v:
  4. 4
    COVID-19-associated nephritis: early warning for disease severity and complications?

    COVID-19-associated nephritis: early warning for disease severity and complications? Autor Oliver Groß, Onnen Moerer, Manfred Weber, Tobias B. Huber, Simone Scheithauer

    Vydáno 2020
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions

    Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions Autor Vittorio Abbonante, Cristian Gruppi, Diana Rubel, Oliver Groß, Remigio Moratti, Alessandra Balduini

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome

    Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome Autor Oliver Groß, Michael H. Weber, Jochen W.U. Fries, G.A. Müller

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

    Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatr... Autor Oliver Groß, Tim Friede, Reinhard Hilgers, Anke Görlitz, Karsten Gavénis, Raees Ahmed, U Dürr

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy

    Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy Autor Judy Savige, Martin C. Gregory, Oliver Groß, Clifford E. Kashtan, Jie Ding, Frances Flinter

    Vydáno 2013
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss

    Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss Autor Mi Heon Ryu, Onkar P. Kulkarni, Ewa Radomska, Nicolai Miosge, Oliver Groß, Hans‐Joachim Anders

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1

    Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1 Autor A. M. Meyer zum Gottesberge, Oliver Groß, Ursula Becker-Lendzian, Thomas Massing, Wolfgang F. Vogel

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis

    Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis Autor Oliver Groß, Eckhard Schulze-Lohoff, Marie-Louise Koepke, Bogdan Beirowski, Klaus Addicks, Wilhelm Bloch, Neil Smyth, M. Weber

    Vydáno 2004
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

    Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative Autor Clifford E. Kashtan, Jie Ding, Martin C. Gregory, Oliver Groß, Laurence Heidet, Bertrand Knebelmann, Michelle N. Rheault, Christoph Licht

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

    Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy Autor Christian D. Fankhauser, Sophia Sander, Lisa Roth, Oliver Gross, Daniel Eberli, Tullio Sulser, Burkhardt Seifert, J. Beyer, Thomas Hermanns

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome11See Editorial by Abbate and Remuzzi, p. 764.

    Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome11See Editorial by Abbate and Remuzzi, p. 764. Autor Oliver Groß, Bogdan Beirowski, Marie-Louise Koepke, Jeannine Kuck, Michael Reiner, Klaus Addicks, Neil Smyth, Eckhard Schulze-Lohoff, Manfred Weber

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice

    Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice Autor Volha Ninichuk, Oliver Groß, Stephan Segerer, Reinhard Hoffmann, Ewa Radomska, Andrea Buchstaller, Ralf Huss, Nese Akis, Detlef Schlöndorff, Hans‐Joachim Anders

    Vydáno 2006
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations

    Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations Autor Johanna Temme, Frederik Peters, Katharina Lange, Yves Pirson, Laurence Heidet, Roser Torrá, Jean‐Pierre Grünfeld, Manfred Weber, Christoph Licht, G. A. Müller, Oliver Groß

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group

    Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group Autor Clifford E. Kashtan, Jie Ding, Guido Garosi, Laurence Heidet, Laura Massella, Koichi Nakanishi, Kandai Nozu, Alessandra Renieri, Michelle N. Rheault, Fang Wang, Oliver Groß

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study

    Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study Autor Jan Boeckhaus, Julia Hoefele, Korbinian M. Riedhammer, Mato Nagel, Bodo B. Beck, Mira Choi, Maik Gollasch, Carsten Bergmann, Joseph Sonntag, Victoria Troesch, Johanna Stock, Oliver Groß

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport

    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport Autor Oliver Groß, Jan Boeckhaus, Lutz T. Weber, Hiddo J.L. Heerspink, James Simon, Rees Ahmed, Christoph Gerst, Ulrike Duerr, Florian Walker, Ralf Tostmann, Jürgen Helm, Thomas Asendorf, Tim Friede

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria

    DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria Autor Oliver Groß, Bogdan Beirowski, Scott J. Harvey, Catherine McFadden, Dilys Chen, Stephanie Tam, Paul S. Thorner, Neil Smyth, Klaus Addicks, Wilhelm Bloch, Yoshifumi Ninomiya, Yoshikazu Sado, Manfred Weber, Wolfgang F. Vogel

    Vydáno 2004
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: